Search

Your search keyword '"Pache, Florence"' showing total 199 results

Search Constraints

Start Over You searched for: Author "Pache, Florence" Remove constraint Author: "Pache, Florence"
199 results on '"Pache, Florence"'

Search Results

1. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients

4. Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes

5. Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations

6. Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions

9. sj-docx-1-msj-10.1177_13524585231161253 – Supplemental material for Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations

13. Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study

14. Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation

15. Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20 treated patients with multiple sclerosis after three or four COVID-19 vaccinations

16. Frequent intrathecal production of antibodies to the viral capsid antigen of Epstein-Barr virus in patients with central nervous system post-transplant lymphoproliferative disorder

18. Additional file 1 of Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients

19. sj-docx-6-msj-10.1177_13524585221094478 – Supplemental material for Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis

20. sj-doc-5-msj-10.1177_13524585221094478 – Supplemental material for Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis

21. sj-doc-1-msj-10.1177_13524585221094478 – Supplemental material for Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis

22. Neuromyelitis Optica: Evaluation of 871 Attacks and 1,153 Treatment Courses

25. A cohort of 222 anti-CD20 treated patients with multiple sclerosis followed through the COVID-19 pandemic: Attenuated humoral but robust cellular immune responses after vaccination and infection

26. Successful plasmapheresis and immunoglobulin treatment for severe lipid storage myopathy: Doing the right thing for the wrong reason

27. Additional file 1 of Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes

28. Binding patterns and functional properties of human antibodies to AQP4 and MOG on murine optic nerve and retina

29. Successful plasmapheresis and immunoglobulin treatment for severe lipid storage myopathy: Doing the right thing for the wrong reason.

30. Apheresis therapies for NMOSD attacks : a retrospective study of 207 therapeutic interventions

32. Neuromyelitis optica

33. Additional file 1: Table S1. of MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients

34. Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

35. Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD

36. Neuromyelitis optica

37. Longitudinal Intravital Imaging of the Retina Reveals Long-term Dynamics of Immune Infiltration and Its Effects on the Glial Network in Experimental Autoimmune Uveoretinitis, without Evident Signs of Neuronal Dysfunction in the Ganglion Cell Layer

38. Differentielle Aktivierung des NLRP3-Inflammasoms durch Pneumolysin

40. Multifrequency magnetic resonance elastography of the brain reveals tissue degeneration in neuromyelitis optica spectrum disorder

41. Human cerebrospinal fluid monoclonalN-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis

42. MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T

44. Neuronal Afferent Visual System Damage in MOG-Antibody Associated Optic Neuritis Is as Severe as in AQP4-Antibody Positive NMOSD (P4.275)

46. Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis

47. Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis

49. Serotype 1 and 8 Pneumococci Evade Sensing by Inflammasomes in Human Lung Tissue

50. Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica

Catalog

Books, media, physical & digital resources